Cadrenal Therapeutics, Inc.
Recent Filings
All 222 filings →| Form | Description | Date |
|---|---|---|
| 8-K | CURRENT REPORT | Mar 12, 2026 |
| 8-K | CURRENT REPORT | Feb 24, 2026 |
| 424B3 | PROSPECTUS | Jan 2, 2026 |
| EFFECT | — | Dec 31, 2025 |
| D | — | Dec 31, 2025 |
| 4 | — | Dec 31, 2025 |
| 144 | — | Dec 29, 2025 |
| S-1 | REGISTRATION STATEMENT | Dec 29, 2025 |
| 8-K | CURRENT REPORT | Dec 23, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | Dec 23, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Szot Matthew K | Chief Financial Officer | Sale | 9,933 @ $6.97 | — | Dec 29, 2025 |
| Szot Matthew K | Chief Financial Officer | Sale | 1,800 @ $13.99 | 11,733 | Oct 27, 2025 |
| Pham Quang X | CEO and Chairman | Sale | 1,315 @ $13.99 | 196,089 | Oct 24, 2025 |
| Pham Quang X | CEO and Chairman | Sale | 1,800 @ $14.02 | 200,333 | Oct 13, 2025 |
| Szot Matthew K | Chief Financial Officer | Sale | 1,800 @ $14.07 | 13,533 | Oct 9, 2025 |
| Szot Matthew K | Chief Financial Officer | Sale | 107 @ $13.99 | 17,026 | Oct 6, 2025 |
| Pham Quang X | CEO and Chairman | Sale | 500 @ $14.13 | 202,133 | Oct 2, 2025 |
| Pham Quang X | CEO and Chairman | Sale | 419 @ $14.01 | 203,514 | Oct 1, 2025 |
| Szot Matthew K | Chief Financial Officer | Sale | 1,700 @ $13.99 | 17,133 | Sep 29, 2025 |
| Szot Matthew K | Chief Financial Officer | Sale | 1,500 @ $14.00 | 29,833 | Sep 25, 2025 |